Host defenses against viral disease.
D000547:Amantadine / Q000627:therapeutic use; D000818:Animals; D000914:Antibodies, Viral; D000917:Antibody Formation; D000956:Antigens, Viral; D001402:B-Lymphocytes / Q000276:immunology; D001666:Binding Sites, Antibody; D006564:Herpesviridae / Q000276:immunology; D006566:Herpesviridae Infections / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular; D007369:Interferon Inducers / Q000627:therapeutic use; D007372:Interferons / Q000627:therapeutic use; D007700:Kinetics; D008264:Macrophages / Q000276:immunology; D051379:Mice; D010587:Phagocytosis; D013045:Species Specificity; D013601:T-Lymphocytes / Q000276:immunology; D014765:Viral Vaccines; D014777:Virus Diseases / Q000276:immunology* / Q000628:therapy; D014779:Virus Replication
D000914:Antibodies, Viral; D000956:Antigens, Viral; D007369:Interferon Inducers; D014765:Viral Vaccines; D007372:Interferons; D000547:Amantadine